Literature DB >> 7514401

Human monocyte chemotactic proteins-2 and 3 (MCP-2 and MCP-3) attract human eosinophils and desensitize the chemotactic responses towards RANTES.

N Noso1, P Proost, J Van Damme, J M Schröder.   

Abstract

When synthetic monocyte chemotactic proteins (MCPs) were tested in a Boyden chamber assay system for eosinophil-chemotactic properties using human eosinophils, MCP-3 was found to be a potent and efficient (percentage input migrating cells) attractant with an ED50 near 2-3 nM. MCP-2 was less potent, exhibiting half maximal chemotaxis at 40 nM. Cross desensitization experiments of eosinophil-chemotaxis revealed that both MCP-3 and MCP-2 desensitized autologous responses. In addition, pretreatment of human eosinophils with natural RANTES desensitized chemotaxis towards MCP-3 as well as MCP-2, whereas pretreatment of eosinophils with MCP-3 desensitized, apart from responses to MCP-3, also responses against RANTES and MCP-2. These findings indicate that possibly both MCP-3 and MCP-2 elicit chemotactic responses via the RANTES-receptor on eosinophils.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7514401     DOI: 10.1006/bbrc.1994.1616

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

Review 1.  Pathogenesis and classification of eosinophil disorders: a review of recent developments in the field.

Authors:  Peter Valent; Gerald J Gleich; Andreas Reiter; Florence Roufosse; Peter F Weller; Andrzej Hellmann; Georgia Metzgeroth; Kristin M Leiferman; Michel Arock; Karl Sotlar; Joseph H Butterfield; Sabine Cerny-Reiterer; Matthias Mayerhofer; Peter Vandenberghe; Torsten Haferlach; Bruce S Bochner; Jason Gotlib; Hans-Peter Horny; Hans-Uwe Simon; Amy D Klion
Journal:  Expert Rev Hematol       Date:  2012-04       Impact factor: 2.929

2.  Identification of human complement factor H as a chemotactic protein for monocytes.

Authors:  K Nabil; B Rihn; M C Jaurand; J M Vignaud; J Ripoche; Y Martinet; N Martinet
Journal:  Biochem J       Date:  1997-09-01       Impact factor: 3.857

3.  The C-C chemokine receptor CCR3 participates in stimulation of eosinophil arrest on inflammatory endothelium in shear flow.

Authors:  J Kitayama; C R Mackay; P D Ponath; T A Springer
Journal:  J Clin Invest       Date:  1998-05-01       Impact factor: 14.808

Review 4.  Chemokines and tissue injury.

Authors:  M B Furie; G J Randolph
Journal:  Am J Pathol       Date:  1995-06       Impact factor: 4.307

5.  Increased expression of IP-10, IL-8, MCP-1, and MCP-3 in ulcerative colitis.

Authors:  M Uguccioni; P Gionchetti; D F Robbiani; F Rizzello; S Peruzzo; M Campieri; M Baggiolini
Journal:  Am J Pathol       Date:  1999-08       Impact factor: 4.307

6.  Transcriptional and post-transcriptional regulation of monocyte chemoattractant protein-3 gene expression in human endothelial cells by phorbol ester and cAMP signalling.

Authors:  A Kondo; S Isaji; Y Nishimura; T Tanaka
Journal:  Immunology       Date:  2000-04       Impact factor: 7.397

7.  IL-5 and TNF-alpha participate in recruitment of eosinophils to intestinal mucosa in ulcerative colitis.

Authors:  M Lampinen; M Carlson; P Sangfelt; Y Taha; M Thörn; L Lööf; Y Raab; P Venge
Journal:  Dig Dis Sci       Date:  2001-09       Impact factor: 3.199

8.  Association of serum cytokines with colorectal polyp number and type in adult males.

Authors:  Sarah S Comstock; Diana Xu; Kari Hortos; Bruce Kovan; Sarah McCaskey; Dorothy R Pathak; Jenifer I Fenton
Journal:  Eur J Cancer Prev       Date:  2016-05       Impact factor: 2.497

9.  Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody.

Authors:  H Heath; S Qin; P Rao; L Wu; G LaRosa; N Kassam; P D Ponath; C R Mackay
Journal:  J Clin Invest       Date:  1997-01-15       Impact factor: 14.808

10.  Induction of mRNA for chemokines and chemokine receptors by prostaglandin F2α is dependent upon stage of the porcine corpus luteum and intraluteal progesterone.

Authors:  Wenxiang Luo; Francisco J Diaz; Milo C Wiltbank
Journal:  Endocrinology       Date:  2011-04-19       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.